8-KExhibits & Filings

JPMORGAN CHASE & CO 8-K Report, Exhibit Filing (Apr 16, 2007)

Filed April 16, 2007For Securities:JPMJPM-PCJPM-PDJPM-PKJPM-PLJPM-PMJPM-PJAMJBVYLD

Summary

This 8-K filing from JPMorgan Chase & Co. (JPM) on April 16, 2007, primarily serves to disclose an exhibit related to a specific debt issuance. The key item reported is the filing of a Tax Opinion from Davis Polk & Wardwell concerning 6.925% Reverse Exchangeable Notes due July 18, 2007. These notes are linked to the common stock of NutriSystem, Inc., and carry a significant annual yield equivalent of 27.70% per annum. For investors, this filing signals JPMorgan's engagement in structured product offerings. The Reverse Exchangeable Notes represent a complex financial instrument where the return and principal repayment are tied to the performance of an underlying asset, in this case, NutriSystem stock. The high stated yield suggests a higher risk profile associated with the product, likely due to its principal at-risk nature or other derivative components.

Key Highlights

  • 1JPMorgan Chase & Co. filed an 8-K on April 16, 2007.
  • 2The filing's primary purpose is to present an exhibit related to a specific financial product.
  • 3The exhibit is a Tax Opinion from Davis Polk & Wardwell.
  • 4This opinion concerns 6.925% Reverse Exchangeable Notes due July 18, 2007.
  • 5The notes are linked to the common stock of NutriSystem, Inc.
  • 6These notes have a stated equivalent annual yield of 27.70% per annum.

Frequently Asked Questions